Biotalys NV (FRA:86C)

Market Cap	172.59M
Revenue (ttm)	n/a
Net Income (ttm)	-14.83M
Shares Out	n/a
EPS (ttm)	-0.42
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	4.450
Previous Close	4.550
Day's Range	4.450 - 4.450
52-Week Range	2.740 - 5.200
Beta	n/a
RSI	45.93
Earnings Date	Mar 19, 2026

About Biotalys NV

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Employees: 63
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 86C